SCHEMBL17878732

SCHEMBL17878732

CC(C)(C)OC(=O)NC[C@H](N)C(=O)OCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.65
IDO1 P14902 1/20 0.48
LTA4H P09960 1/20 0.47
CTSS P25774 3/20 0.46
PPARA Q07869 1/20 0.46
ATM Q13315 1/20 0.46
NTSR1 P30989 1/20 0.46
MAPT P10636 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SLC1A3 P43003 1/20 0.45
SLC1A1 P43005 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CTSL P07711 2/20 0.44
CTSB P07858 1/20 0.44
CTSK P43235 1/20 0.44
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA7 P43166 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29879918 1.00 SYK (0.65) SYKIDO1LTA4HCTSSPPARA
SCHEMBL2367757 0.90 SYK (0.60) SYKIDO1LTA4HCTSSPPARA
SCHEMBL6500075 0.90 SYK (0.61) SYKLTA4HCTSSMAPTL3MBTL1
SCHEMBL17878734 0.87 SYK (0.56) SYKIDO1LTA4HCTSSPPARA
SCHEMBL23489473 0.87 SYK (0.54) SYKCTSSPPARAATMNTSR1
SCHEMBL1627707 0.86 SYK (0.67) SYKIDO1CTSSPPARAATM
SCHEMBL1627709 0.86 SYK (0.61) SYKIDO1LTA4HCTSSPPARA
SCHEMBL29398484 0.86 SLC1A3 (0.58) SYKL3MBTL1SLC1A3SLC1A1SMN1; SMN2
SCHEMBL21164376 0.85 MAPT (0.55) SYKIDO1LTA4HMAPTL3MBTL1
SCHEMBL7979181 0.84 MAPT (0.59) SYKIDO1MAPTL3MBTL1SLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233889-B1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS SHANGHAI MICURX PHARMACEUTICAL CO LTD (CN) 2022-07-06 EP disclosed
US-9771394-B2 Antimicrobial polymyxins for treatment of bacterial infections MICURX PHARMACEUTICALS, INC. (KY) 2017-09-26 US disclosed
US-20160185823-A1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS MICURX PHARMACEUTICALS, INC. 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185823-A1 ANTIMICROBIAL POLYMYXINS FOR TREATMENT OF BACTERIAL INFECTIONS VIP, AQP1, PEF1 SYK 1484/4885IDO1 3657/4885LTA4H 1192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.